Is Adjuvant Immunotherapy Worth for All Patients with Clear-cell Renal Cell Carcinoma at High Risk of Recurrence?

Eur Urol Open Sci. 2022 Oct 25:46:39-42. doi: 10.1016/j.euros.2022.10.002. eCollection 2022 Dec.
No abstract available